Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate

The title compound, C15H22N4O5S, was prepared via alkylation of 3-(chloromethyl)-5-(pentan-3-yl)-1,2,4-oxadiazole in anhydrous dioxane in the presence of triethylamine. The thiadiazine ring has an envelope conformation with the S atom displaced by 0.4883 (6) Å from the mean plane through the other f...

Full description

Bibliographic Details
Main Authors: Alexandre V. Ivachtchenko, Sergiy M. Kovalenko, Dmitry V. Kravchenko, Oleg D. Mitkin, Vladimir V. Ivanov, Thierry Langer
Format: Article
Language:English
Published: International Union of Crystallography 2020-01-01
Series:Acta Crystallographica Section E: Crystallographic Communications
Subjects:
Online Access:http://scripts.iucr.org/cgi-bin/paper?S2056989019015986
_version_ 1818941291375886336
author Alexandre V. Ivachtchenko
Sergiy M. Kovalenko
Dmitry V. Kravchenko
Oleg D. Mitkin
Vladimir V. Ivanov
Thierry Langer
author_facet Alexandre V. Ivachtchenko
Sergiy M. Kovalenko
Dmitry V. Kravchenko
Oleg D. Mitkin
Vladimir V. Ivanov
Thierry Langer
author_sort Alexandre V. Ivachtchenko
collection DOAJ
description The title compound, C15H22N4O5S, was prepared via alkylation of 3-(chloromethyl)-5-(pentan-3-yl)-1,2,4-oxadiazole in anhydrous dioxane in the presence of triethylamine. The thiadiazine ring has an envelope conformation with the S atom displaced by 0.4883 (6) Å from the mean plane through the other five atoms. The planar 1,2,4-oxadiazole ring is inclined to the mean plane of the thiadiazine ring by 77.45 (11)°. In the crystal, molecules are linked by C—H...N hydrogen bonds, forming chains propagating along the b-axis direction. Hirshfeld surface analysis and two-dimensional fingerprint plots have been used to analyse the intermolecular contacts present in the crystal. Molecular docking studies were use to evaluate the title compound as a potential system that interacts effectively with the capsid of the Hepatitis B virus (HBV), supported by an experimental in vitro HBV replication model.
first_indexed 2024-12-20T06:53:12Z
format Article
id doaj.art-2d9eab74010f4535842a0f89b10e00a2
institution Directory Open Access Journal
issn 2056-9890
language English
last_indexed 2024-12-20T06:53:12Z
publishDate 2020-01-01
publisher International Union of Crystallography
record_format Article
series Acta Crystallographica Section E: Crystallographic Communications
spelling doaj.art-2d9eab74010f4535842a0f89b10e00a22022-12-21T19:49:26ZengInternational Union of CrystallographyActa Crystallographica Section E: Crystallographic Communications2056-98902020-01-01761121710.1107/S2056989019015986su5529Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylateAlexandre V. Ivachtchenko0Sergiy M. Kovalenko1Dmitry V. Kravchenko2Oleg D. Mitkin3Vladimir V. Ivanov4Thierry Langer5ChemRar Research and Development Institute, 7 Nobel St, Innovation Center, Skolkovo Territory, Moscow, 143026, Russian FederationChemRar Research and Development Institute, 7 Nobel St, Innovation Center, Skolkovo Territory, Moscow, 143026, Russian FederationChemical Diversity Research Institute, 2A Rabochaya St, Khimki, Moscow Region, 141400, Russian FederationChemRar Research and Development Institute, 7 Nobel St, Innovation Center, Skolkovo Territory, Moscow, 143026, Russian FederationV.N. Karazin Kharkiv National University, 4 Svobody Sq., Kharkiv, 61077, UkraineUniversity of Vienna, Althanstrasse 14, A-1090, Vienna, AustriaThe title compound, C15H22N4O5S, was prepared via alkylation of 3-(chloromethyl)-5-(pentan-3-yl)-1,2,4-oxadiazole in anhydrous dioxane in the presence of triethylamine. The thiadiazine ring has an envelope conformation with the S atom displaced by 0.4883 (6) Å from the mean plane through the other five atoms. The planar 1,2,4-oxadiazole ring is inclined to the mean plane of the thiadiazine ring by 77.45 (11)°. In the crystal, molecules are linked by C—H...N hydrogen bonds, forming chains propagating along the b-axis direction. Hirshfeld surface analysis and two-dimensional fingerprint plots have been used to analyse the intermolecular contacts present in the crystal. Molecular docking studies were use to evaluate the title compound as a potential system that interacts effectively with the capsid of the Hepatitis B virus (HBV), supported by an experimental in vitro HBV replication model.http://scripts.iucr.org/cgi-bin/paper?S2056989019015986crystal structure2h-1,2,6-thiadiazine 1,1-dioxidehepatitis bhbvhydrogen bondinghirshfeld surface analysismolecular docking study
spellingShingle Alexandre V. Ivachtchenko
Sergiy M. Kovalenko
Dmitry V. Kravchenko
Oleg D. Mitkin
Vladimir V. Ivanov
Thierry Langer
Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
Acta Crystallographica Section E: Crystallographic Communications
crystal structure
2h-1,2,6-thiadiazine 1,1-dioxide
hepatitis b
hbv
hydrogen bonding
hirshfeld surface analysis
molecular docking study
title Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
title_full Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
title_fullStr Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
title_full_unstemmed Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
title_short Crystal structure, Hirshfeld analysis and a molecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxadiazol-3-yl]methyl}-2H-1,2,6-thiadiazine-4-carboxylate
title_sort crystal structure hirshfeld analysis and a molecular docking study of a new inhibitor of the hepatitis b virus hbv ethyl 5 methyl 1 1 dioxo 2 5 pentan 3 yl 1 2 4 oxadiazol 3 yl methyl 2h 1 2 6 thiadiazine 4 carboxylate
topic crystal structure
2h-1,2,6-thiadiazine 1,1-dioxide
hepatitis b
hbv
hydrogen bonding
hirshfeld surface analysis
molecular docking study
url http://scripts.iucr.org/cgi-bin/paper?S2056989019015986
work_keys_str_mv AT alexandrevivachtchenko crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate
AT sergiymkovalenko crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate
AT dmitryvkravchenko crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate
AT olegdmitkin crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate
AT vladimirvivanov crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate
AT thierrylanger crystalstructurehirshfeldanalysisandamoleculardockingstudyofanewinhibitorofthehepatitisbvirushbvethyl5methyl11dioxo25pentan3yl124oxadiazol3ylmethyl2h126thiadiazine4carboxylate